11/3/2016 1:39:54 PM
Wedbush Is Lowering Achillion Pharmaceuticals Inc. (ACHN) 2017 Estimate To -0.71 From -0.68
11/3/2016 1:39:36 PM
Wedbush Is Lowering Achillion Pharmaceuticals Inc. (ACHN) Q4 17 Estimate To -0.19 From -0.18
11/3/2016 1:39:22 PM
Wedbush Is Cutting Achillion Pharmaceuticals Inc. (ACHN) Q3 17 Estimate To -0.18 From -0.17
11/3/2016 1:39:07 PM
Wedbush Is Lowering Achillion Pharmaceuticals Inc. (ACHN) Q1 17 Estimate To -0.17 From -0.16
11/3/2016 1:38:50 PM
Wedbush Is Lowering Achillion Pharmaceuticals Inc. (ACHN) 2016 Estimate To -0.58 From -0.56
11/3/2016 1:38:31 PM
Wedbush Is Cutting Achillion Pharmaceuticals Inc. (ACHN) Q4 16 Estimate To -0.16 From -0.15
11/3/2016 1:38:18 PM
Wedbush Reiterates Achillion Pharmaceuticals Inc. (ACHN) At Outperform With $13 Price Target
9/23/2016 3:35:49 PM
Wedbush Reiterates Achillion Pharmaceuticals Inc. (ACHN) At Outperform With $13 Price Target
9/22/2016 4:21:20 PM
Wedbush Initiates Achillion Pharmaceuticals Inc. (ACHN) At Outperform With $13 Price Target
12/8/2015 7:19:22 AM
William Blair Reiterates Achillion Pharmaceuticals Inc. (ACHN) At Outperform With $16 Price Target
9/4/2013 12:44:04 PM
Deutsche Bank Is Lowering Achillion Pharmaceuticals Inc. (ACHN) FY13 Estimate To -0.78 From -0.71
4/23/2013 12:33:37 PM
Deutsche Bank Reiterates Achillion Pharmaceuticals Inc. (ACHN) At Buy With $17 Price Target
9/19/2012 1:26:48 PM
Deutsche Bank Starts Achillion Pharmaceuticals Inc. (ACHN) At Buy With $12 Price Target
5/10/2012 7:44:33 AM
Robert W. Baird Is Increasing Achillion Pharmaceuticals Inc. (ACHN) FY13 Estimate To -0.67 From -0.68
5/10/2012 7:43:57 AM
Robert W. Baird Is Raising Achillion Pharmaceuticals Inc. (ACHN) FY12 Estimate To -0.65 From -0.66
3/9/2012 8:11:06 AM
Robert W. Baird Is Lowering Achillion Pharmaceuticals Inc. (ACHN) FY 13 Estimate To -0.68 From -0.67
3/9/2012 8:10:52 AM
Robert W. Baird Is Increasing Achillion Pharmaceuticals Inc. (ACHN) FY 12 Estimate To -0.66 From -0.67
11/9/2011 8:54:58 AM
Robert W. Baird Is Lowering Achillion Pharmaceuticals Inc. (ACHN) FY12 Estimate To -0.67 From -0.66
11/9/2011 8:54:40 AM
Robert W. Baird Is Increasing Achillion Pharmaceuticals Inc. (ACHN) FY11 Estimate To -0.66 From -0.69
8/25/2011 7:34:54 AM
Robert W. Baird Initiates Achillion Pharmaceuticals Inc. (ACHN) At Outperform With $9 Price Target